Post-transplantation cyclophosphamide restores early B-cell lymphogenesis that suppresses subsequent chronic graft-versus-host disease

Bone Marrow Transplant. 2021 Apr;56(4):956-959. doi: 10.1038/s41409-020-01100-0. Epub 2020 Oct 30.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • B-Lymphocytes
  • Cyclophosphamide
  • Graft vs Host Disease* / drug therapy
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Transplantation Conditioning

Substances

  • Cyclophosphamide